POLR1A

POLR1A encodes the largest catalytic subunit of RNA polymerase I, the enzyme dedicated to rDNA transcription and the production of pre-rRNA that drives ribosome biogenesis (PMID:2830265, PMID:3054507). Work in yeast established that this subunit is essential for viability and carries conserved homology regions shared with other large polymerase subunits, including an N-terminal zinc-binding motif implicated in DNA binding; temperature-sensitive mutations mapping to this zinc region and to other conserved blocks abolish rRNA transcription in vivo and Pol I activity in vitro, directly placing POLR1A at the enzyme's catalytic core (PMID:2830265, PMID:3054507). Reduced POLR1A activity preferentially diminishes rRNA synthesis, with excess ribosomal proteins subsequently cleared by post-translational degradation to match the lowered rRNA level (PMID:2183018). In humans and vertebrate models, POLR1A mutations impair ribosome biogenesis and trigger p53-dependent apoptosis preferentially in neural-crest-derived skeletal precursors, causing acrofacial dysostosis, and conditional loss in defined developmental lineages produces cell-autonomous apoptosis and malformations (PMID:25913037, PMID:37075751); other pathogenic variants reduce nucleolar Pol I protein, disrupt pre-rRNA processing and nucleolar homeostasis, and propagate to ER stress and proteostasis failure, manifesting as leukodystrophy and neurodegeneration (PMID:28051070, PMID:36917474). Beyond canonical transcription, POLR1A is stabilized within nucleolar fibrillar centers by phase-separating nuclear p85β (PIK3R2) to enhance rRNA biosynthesis in hepatocellular carcinoma (PMID:42212331), and it promotes ferroptosis resistance through an ATF4–TFAM axis that suppresses mitophagy-dependent labile Fe²⁺ release, with Pol I inhibition synergizing with GPX4 blockade to induce ferroptotic death (PMID:40669210).

1. 1988 High

   Establishing what the largest Pol I subunit is and whether it is essential answered the foundational question of POLR1A's identity and necessity for cell life.

   Evidence Gene isolation and disruption with viability readout plus sequence comparison in yeast RPA190

   PMID:2830265

   Open questions at the time

   • Catalytic contribution of the zinc-binding motif inferred from sequence homology, not yet functionally tested at this stage
   • Human ortholog function not addressed
2. 1988 High

   Mapping temperature-sensitive mutations to conserved regions and showing defective transcription answered whether POLR1A is directly catalytic for rDNA transcription rather than merely structural.

   Evidence Mutagenesis, plasmid shuffle, in vivo pulse-label rRNA analysis, and in vitro transcription with defined yeast mutants

   PMID:3054507

   Open questions at the time

   • Atomic-level catalytic mechanism not resolved
   • Did not establish how mutations alter enzyme assembly versus catalysis
3. 1990 High

   Conditional depletion answered how lowered Pol I activity is buffered, showing rRNA synthesis is rate-limiting and excess ribosomal proteins are degraded post-translationally.

   Evidence GAL1 promoter replacement with pulse-chase labeling, polysome analysis, and Northern blotting in yeast

   PMID:2183018

   Open questions at the time

   • Degradation machinery for excess ribosomal proteins not identified
   • Relevance to metazoan cells not established
4. 2015 High

   Modeling human mutations in zebrafish answered why POLR1A defects cause tissue-specific disease, linking impaired ribosome biogenesis to p53-dependent neural crest apoptosis.

   Evidence Zebrafish polr1a loss-of-function with ribosome biogenesis, p53 pathway, and neural crest fate analysis

   PMID:25913037

   Open questions at the time

   • Why neural crest is selectively vulnerable not mechanistically resolved
   • Direct demonstration in human tissue absent
5. 2017 Medium

   Identifying a missense variant in a leukodystrophy patient extended the POLR1A disease spectrum and tied loss-of-function to reduced nucleolar Pol I protein and neurodegeneration.

   Evidence Exome sequencing, segregation analysis, and immunofluorescence of patient fibroblasts for nucleolar RPA194

   PMID:28051070

   Open questions at the time

   • No in vitro reconstitution or enzymatic assay performed
   • Mechanism linking protein loss to neurodegeneration not defined
6. 2023 High

   An allelic series with conditional mouse knockouts answered whether POLR1A requirements are lineage-specific and cell-autonomous across multiple developmental compartments.

   Evidence In vitro rRNA and nucleolar assays plus CRISPR knock-in mice and Cre-lox conditional mutagenesis in neural crest, second heart field, and forebrain

   PMID:37075751

   Open questions at the time

   • Why different lineages show differing thresholds of sensitivity not resolved
   • Variant-specific severity not mapped to enzyme structure
7. 2023 Medium

   Characterizing a processing-defective variant answered how impaired Pol I propagates downstream, linking aberrant pre-rRNA processing to nucleolar dysfunction, ER stress, and proteostasis failure.

   Evidence rRNA processing assays, proteomics, and ER stress markers in patient fibroblasts

   PMID:36917474

   Open questions at the time

   • Single-lab, single patient genotype
   • Causal chain from rRNA defect to ER stress not dissected mechanistically
8. 2025 Medium

   Connecting POLR1A to an ATF4–TFAM axis answered whether Pol I has a non-canonical role in cell death, identifying control of mitophagy-driven iron release and ferroptosis resistance.

   Evidence POLR1A knockdown/inhibition with TFAM analysis, mitophagy, labile iron and lipid peroxidation assays, and CX-5461 + GPX4 inhibitor combination in vitro and in vivo

   PMID:40669210

   Open questions at the time

   • Novel pathway not independently replicated
   • How Pol I activity is mechanistically coupled to ATF4 not defined
9. 2026 Medium

   Demonstrating p85β phase separation and POLR1A stabilization answered how Pol I output is regulated in cancer beyond intrinsic catalysis, via nucleolar condensate formation.

   Evidence Co-IP, nucleolar fractionation, LLPS live-cell imaging, and rRNA biosynthesis knockdown/rescue in hepatocellular carcinoma cells

   PMID:42212331

   Open questions at the time

   • No structural validation of the interaction
   • Single-lab Co-IP without reciprocal in vivo confirmation

• How POLR1A integrates its core transcriptional role with its non-canonical regulation of iron homeostasis and condensate-mediated stabilization remains unresolved.
• No structural model of human POLR1A within Pol I in the corpus
• Mechanistic coupling between Pol I activity and the ATF4–TFAM ferroptosis axis undefined
• Whether p85β condensate regulation operates outside cancer is unknown